Medicare Enrolled
Dr. Arley Peter, M.D.
Cardiovascular Disease · Vero Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Peter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Peter? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Peter
Dr. Arley Peter is a cardiovascular disease in Vero Beach, FL, with 18 years in practice. Based on federal Medicare data, Dr. Peter performed 22,575 Medicare services across 11,663 unique beneficiaries.
Between the years covered by Open Payments, Dr. Peter received a total of $52,283 from 41 pharmaceutical and/or device companies across 526 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Peter is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 1% volume in FL$ $52,283 industry payments
Medicare Practice Summary
Medicare Utilization ↗22,575
Medicare services
Top 1% in FL for cardiovascular disease
11,663
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,254 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month | 4,869 | $51 | $126 |
| Office visit, established patient (30-39 min) | 3,641 | $99 | $260 |
| Electrocardiogram (EKG), 12-lead | 1,521 | $11 | $36 |
| Echocardiogram, transthoracic | 1,136 | $142 | $462 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 1,116 | $0 | $5 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 756 | $20 | $55 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 755 | $28 | $55 |
| Hospital follow-up visit, moderate complexity | 739 | $65 | $148 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 716 | $90 | $472 |
| Chronic care management, additional 20 min/month | 684 | $38 | $95 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 505 | $51 | $155 |
| Remote pacemaker/defibrillator monitoring, 90 days | 455 | $17 | $53 |
| Ultrasound of both sides of head and neck blood flow | 434 | $150 | $417 |
| New patient office visit (45-59 min) | 415 | $124 | $345 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 363 | $150 | $406 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 358 | $352 | $994 |
| Remote pacemaker monitoring, 90 days | 345 | $22 | $70 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 334 | $47 | $130 |
| Office visit, established patient (20-29 min) | 324 | $68 | $185 |
| Office visit, established patient, complex (40-54 min) | 246 | $140 | $370 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 231 | $54 | $186 |
| Regadenoson injection (Lexiscan) for heart stress test | 208 | $42 | $228 |
| Initial hospital admission, moderate complexity | 174 | $105 | $283 |
| Heart muscle strain imaging | 151 | $31 | $84 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 150 | $11 | $32 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 131 | $139 | $397 |
| Programming of dual lead pacemaker system | 127 | $28 | $160 |
| Transitional care management services for problem of high complexity | 125 | $225 | $560 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 122 | $95 | $249 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 109 | $27 | $139 |
| Ultrasound of heart, follow-up | 104 | $74 | $252 |
| Programming of cardiac rhythm monitor system | 78 | $18 | $120 |
| Ultrasound of heart with probe in esophagus, with report | 75 | $82 | $224 |
| Initial hospital admission, high complexity | 73 | $142 | $417 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 72 | $21 | $54 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 72 | $663 | $1,478 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 66 | $70 | $184 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 66 | $11 | $30 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 63 | $19 | $52 |
| Hospital follow-up visit, high complexity | 62 | $100 | $214 |
| External shock to heart to regulate heart beat | 51 | $89 | $422 |
| Cardiac catheterization | 51 | $252 | $826 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 50 | $1,373 | $4,380 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 47 | $20 | $55 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 47 | $58 | $141 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 43 | $51 | $127 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 42 | $109 | $266 |
| Programming of multiple lead implantable defibrillator system | 38 | $48 | $210 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 31 | $315 | $1,052 |
| Insertion of heart rhythm monitor under skin | 24 | $3,551 | $10,170 |
| Programming of dual lead implantable defibrillator system | 22 | $42 | $200 |
| Removal of heart rhythm monitor from under the skin | 21 | $101 | $378 |
| Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | 19 | $1,073 | $2,845 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 19 | $874 | $3,192 |
| Programming of single lead pacemaker system | 19 | $20 | $130 |
| New patient office visit, complex (60-74 min) | 18 | $182 | $450 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $41 | $110 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 16 | $156 | $551 |
| New patient office visit (30-44 min) | 16 | $94 | $230 |
| Ultrasound of leg arteries or artery grafts | 14 | $189 | $535 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.3% high complexity
16.3% medium
72.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$52,283
Total received (2018-2024)
Avg $7,469/year across 7 years
Top 8% in FL for cardiovascular disease
41
Companies
526
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$38,039 (72.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,244 (27.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,877
2023$9,627
2022$9,818
2021$8,366
2020$5,762
2019$8,641
2018$5,193
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$38,224
Medtronic Vascular, Inc.
$5,597
Abbott Laboratories
$1,057
Medtronic, Inc.
$871
Novartis Pharmaceuticals Corporation
$633
Boston Scientific Corporation
$589
AstraZeneca Pharmaceuticals LP
$548
Amgen Inc.
$516
PFIZER INC.
$478
SANOFI-AVENTIS U.S. LLC
$396
Boehringer Ingelheim Pharmaceuticals, Inc.
$337
E.R. Squibb & Sons, L.L.C.
$307
BIOTRONIK INC.
$291
Janssen Pharmaceuticals, Inc
$287
Merck Sharp & Dohme LLC
$203
CVRx, Inc.
$197
Bayer HealthCare Pharmaceuticals Inc.
$177
Edwards Lifesciences Corporation
$169
Lexicon Pharmaceuticals, Inc.
$167
Gilead Sciences, Inc.
$152
Allergan Inc.
$149
Amarin Pharma Inc.
$145
Akcea Therapeutics, Inc.
$125
Kiniksa Pharmaceuticals, Ltd.
$98
Resmed Corp
$76
Regeneron Healthcare Solutions, Inc.
$70
Esperion Therapeutics, Inc.
$69
Kestra Medical Technology Services, Inc.
$68
Kiniksa Pharmaceuticals International, plc
$36
iRhythm Technologies, Inc.
$34
Impulse Dynamics (USA) Inc.
$27
United Therapeutics Corporation
$26
InfoBionic, Inc
$26
Bardy Diagnostics, Inc.
$25
VivaQuant Inc, dba Rhythm Express
$22
ATRICURE, INC.
$18
Novo Nordisk Inc
$18
Baxter Healthcare
$16
Tactile Systems Technology Inc
$13
ARBOR PHARMACEUTICALS, INC.
$13
Coala Life Inc
$13
Top 3 companies account for 85.8% of total payments
Associated products mentioned in payments ›
AIRSENSE · AMPLATZER AMULET · ASSURITY · AVEIR · Acticor · Adempas · Advisa · Arcalyst · Assure WCD · Assurity Pacemaker · Attain · Azure · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CLOSUREFAST · CONFIRM RX · CardioMEMS HF System · CareLink · Carnation Ambulatory Monitor · ClosureFast · ClosureRFS · Coala Heart Monitor · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · FARXIGA · Flexitouch Plus · HeartMate 3 Left Ventricular Dev · Hillrom - Cardiac Ambulatory Monitor · Inpefa · JARDIANCE · Kerendia · LEQVIO · LOKELMA · Letairis · LifeVest · MERLIN@HOME · MICRA · MITRACLIP · MULTAQ · Micra · Mitra Clip system · MoMe Kardia · NEXLETOL · NEXLIZET · OPTIMIZER · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RESONATE · REVEAL LINQ · Repatha · Reveal LINQ · Rhythm Express · SAPIEN 3 Ultra RESILIA · TEGSEDI · TYRX · TYVASO · VENASEAL · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · VenaSeal · Visia AF · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · Xience Sierra Coronary Stent System · ZIO Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (73%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for cardiovascular disease in FL.
Equivalent to $232 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
43
Per 100K population
26.2
County median income
$71,049
Nearest hospital
CLEVELAND CLINIC INDIAN RIVER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Peter is a clinical cardiology specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (speaking/promotional, top 8%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Peter experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Peter performed 4,869 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Peter receive payments from pharmaceutical companies?
Yes. Dr. Peter received a total of $52,283 from 41 companies across 526 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Peter's costs compare to other cardiovascular diseases in Vero Beach?
Dr. Peter's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Peter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Vero Beach
Browse cardiovascular diseases in Vero Beach ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology